OTLK
Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)
OTLK Filings
Filing Date
Form Description
Form Type
2026-03-11
Form 8-K - Current report
Key Events
2026-03-11 · Key Events
Form 8-K - Current report
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-03-05
Form 8-K - Current report
Key Events
2026-03-05 · Key Events
Form 8-K - Current report
2026-02-18
Form 8-K - Current report
Key Events
2026-02-18 · Key Events
Form 8-K - Current report
2026-02-17
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-17 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-02-17
Form 8-K - Current report
Key Events
2026-02-17 · Key Events
Form 8-K - Current report
2026-02-11
Form 8-K - Current report
Key Events
2026-02-11 · Key Events
Form 8-K - Current report
2026-02-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-26
Form ARS - Annual Report to Security Holders
2026-01-26 ·
Form ARS - Annual Report to Security Holders
2026-01-26
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2026-01-26 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
